About the Pulmonary Cancer Session
Pulmonary cancer, commonly known as lung cancer, remains one of the most prevalent and lethal forms of cancer worldwide. Research efforts in this field are multifaceted, aiming to understand its intricate biology, improve early detection methods, and develop more effective treatments. From exploring the role of genetic mutations to investigating environmental factors such as smoking and air pollution, scientists strive to unravel the complexities underlying pulmonary cancer. Innovative approaches like immunotherapy and targeted therapies offer promising avenues for personalized treatment, while advancements in imaging techniques enhance diagnostic accuracy. Collaboration between researchers, clinicians, and patients drives progress in this challenging yet vital area of cancer research, with the ultimate goal of improving outcomes and quality of life for those affected by pulmonary cancer.
Topics Covered in Pulmonary Cancer
Non-Small Cell Carcinoma
Small Cell Carcinoma
Low-Dose CT Screening
EGFR & ALK Alterations
Checkpoint Inhibitors
Tobacco & Air Pollution
Related Scientific Sessions at CIOC 2027
Why Attend the Pulmonary Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Pulmonary Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Pulmonary Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Pulmonary Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Pulmonary Cancer Conference 2027 — FAQs
What is the Pulmonary Cancer track at CIOC 2027?
The Pulmonary Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Pulmonary Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Pulmonary Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Pulmonary Cancer are all welcome — whether presenting or attending.
Can I present my research in the Pulmonary Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Pulmonary Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Pulmonary Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.